Platelets stimulate programmed death-ligand 1 expression by cancer cells: Inhibition by anti-platelet drugs.

血小板活化 药理学 细胞凋亡 细胞生物学 医学
作者
Amir Asgari,Gabriela Lesyk,Erika Poitras,Natasha Govindasamy,Kara Terry,Rachel To,Valentina Back,Jan K. Rudzinski,John D. Lewis,Paul Jurasz
出处
期刊:Journal of Thrombosis and Haemostasis [Wiley]
卷期号:19 (11): 2862-2872
标识
DOI:10.1111/jth.15478
摘要

Background Platelets facilitate hematogenous metastasis in part by promoting cancer cell immunoevasion, although our understanding of platelet function in modulating the adaptive immune system in cancer is limited. A major negative regulator of the adaptive response is the immune checkpoint protein Programmed Death Ligand 1 (PD-L1). Objectives As platelets secrete factors that may increase PD-L1 expression, we investigated whether they up-regulate cancer cell PD-L1, thus promoting immunoevasion, and whether common anti-platelet drugs inhibit this process. Methods Platelets were isolated from human volunteers. A549 lung, PD-L1 null A549, and 786-O renal cancer cells were incubated with and without platelets, and cancer cell PD-L1 expression was measured by qPCR and flow cytometry. Additionally, platelet-cancer cell incubations were performed in the presence of common anti-platelet drugs, and with growth factor neutralizing antibodies. Following incubation with platelets, A549 were co-cultured with T-cells and interleukin-2 (IL-2) levels were measured by flow cytometry as a marker of T-cell activation. Results Platelets increased PD-L1 mRNA and surface protein expression by A549 and 786-0 cells. Combined neutralization of VEGF and PDGF prevented the platelet-induced up-regulation of PD-L1 by A549, as did the anti-platelet drug eptifibatide. A549 incubated with platelets demonstrated a reduced ability to activate human T-cells, an effect reversed by eptifibatide. Conclusions As platelets promote immunoevasion of the adaptive immune response by increasing cancer cell PD-L1 expression and as anti-platelet drugs prevent this immunoevasive response, the investigation of anti-platelet drugs as adjuvant therapy to immune checkpoint inhibitors may be warranted in the treatment of cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Azure完成签到,获得积分10
1秒前
2秒前
3秒前
星辰大海应助fwz采纳,获得10
4秒前
4秒前
落寞的问枫完成签到,获得积分20
5秒前
爱笑念波完成签到,获得积分10
5秒前
丘比特应助啊哈采纳,获得10
5秒前
恩恩驳回了情怀应助
6秒前
6秒前
NPC应助如意哑铃采纳,获得10
7秒前
7秒前
刘郭纹完成签到,获得积分10
8秒前
8秒前
kit发布了新的文献求助10
8秒前
大梦想家发布了新的文献求助10
9秒前
9秒前
小小宝完成签到 ,获得积分10
10秒前
11秒前
爱笑念波发布了新的文献求助10
11秒前
842413119完成签到,获得积分10
12秒前
慕青应助卡卡罗特采纳,获得10
12秒前
12秒前
深情映冬发布了新的文献求助10
13秒前
14秒前
14秒前
fwz完成签到,获得积分10
15秒前
aaaxie发布了新的文献求助10
17秒前
深情映冬完成签到,获得积分20
18秒前
SciGPT应助Wt采纳,获得10
18秒前
Ran完成签到,获得积分20
18秒前
19秒前
19秒前
fwz发布了新的文献求助10
20秒前
Grinder驳回了Apple应助
22秒前
乐乐应助笨笨西装采纳,获得10
24秒前
缥缈青文发布了新的文献求助10
24秒前
大模型应助无辜善愁采纳,获得10
24秒前
橙橙妈妈发布了新的文献求助20
24秒前
FashionBoy应助丰富的不惜采纳,获得10
25秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
A Dissection Guide & Atlas to the Rabbit 600
中国心血管健康与疾病报告2023(要完整的报告) 500
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3102795
求助须知:如何正确求助?哪些是违规求助? 2754032
关于积分的说明 7626280
捐赠科研通 2406879
什么是DOI,文献DOI怎么找? 1277068
科研通“疑难数据库(出版商)”最低求助积分说明 617041
版权声明 599103